Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study on the Effects of Garlic on Hyperlipidemia Induced by HAART in HIV-positive Individuals

NCT00029250 is registered in ClinicalTrials.gov with National Center for Complementary and Integrative Health (NCCIH) as lead sponsor.

NCT NCT00029250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00029250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study on the Effects of Garlic on Hyperlipidemia Induced by HAART in HIV-positive Individuals
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Phase
Phase 2
Overall status
Withdrawn
Start date
November 30, 2001
Completion date
May 31, 2003
Enrollment
0 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, hypercholesterolemia, hyperglycemia, hypertriglyceridemia